id
name
processing priority
4
site type
0 (generic, awaiting analysis)
review version
11
html import
20 (imported)
first seen date
2024-01-28 08:18:59
expired found date
-
created at
2024-07-05 14:50:40
updated at
2026-01-12 17:22:45
length
10
crc
33010
tld
2211
nm parts
0
nm random digits
0
nm rare letters
0
is subdomain of id
-
previous id
0
replaced with id
0
related id
-
dns primary id
dns alternative id
0
lifecycle status
0 (unclassified, or currently active)
deleted subdomains
0
page imported products
0
page imported random
0
page imported parking
0
count skipped due to recent timeouts on the same server IP
0
count content received but rejected due to 11-799
0
count dns errors
0
count cert errors
0
count timeouts
0
count http 429
0
count http 404
0
count http 403
0
count http 5xx
0
next operation date
-
server bits
—
server ip
-
mp import status
20
mp rejected date
-
mp saved date
-
mp size orig
116564
mp size raw text
1522
mp inner links count
3
mp inner links status
20 (imported)
title
Amydis - Detecting Ocular Biomarkers for Diseases of the Brain, Eye, and Heart
description
Amydis is the leader in developing a new class of diagnostic compounds that enable digital detection and monitoring of human disease-related molecular biomarkers through standard ocular imaging camera
site name
Amydis -
author
updated
2026-01-11 05:19:19
raw text
Amydis - Detecting Ocular Biomarkers for Diseases of the Brain, Eye, and Heart Skip to content Home About Us Technology Diseases Media Team Contact Us Menu Home About Us Technology Diseases Media Team Contact Us Homepage V3 The Leader in Detecting Ocular Biomarkers for Diseases of the Eye, Heart, and Brain Amydis Powers AI to Enable Precision Healthcare Amydis is the leader in developing a new class of ocular tracers that enable digital detection and monitoring of human disease-related molecular biomarkers through standard ocular imaging cameras. This pioneering technology can accelerate diagnosis, improve the clinical testing of novel therapeutics and revolutionize treatment. MORE The Journey to a Diagnosis is often a Race Against Time Recent Amydis News Amydis Nabs $3.4M NIH Grant to Develop Retinal Biomarkers for Alzheimer’s November 14, 2023 Amydis Receives $3.4 million NIH Commercialization Readiness Pilot Gran...
redirect type
0 (-)
block type
0 (no issues)
detected language
1 (English)
category id
Medicine [en] (226)
index version
2025123101
spam phrases
0
text nonlatin
0
text cyrillic
0
text characters
1151
text words
213
text unique words
116
text lines
53
text sentences
3
text paragraphs
2
text words per sentence
71
text matched phrases
2
text matched dictionaries
3
rss path
rss status
32 (unknown)
rss found date
2024-01-28 16:16:35
rss size orig
268993
rss items
10
rss spam phrases
0
rss detected language
1 (English)
inbefore feed id
-
inbefore status
0 (new)
sitemap path
sitemap status
34 (reserved: import paused pending content quality/relevance assessment after importing first 500 pages)
sitemap review version
2
sitemap urls count
56
sitemap urls adult
0
sitemap filtered products
0
sitemap filtered videos
0
sitemap found date
2024-01-28 08:18:59
sitemap process date
2025-03-01 03:03:09
sitemap first import date
-
sitemap last import date
2025-05-25 05:16:08